Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · IEX Real-Time Price · USD
1.160
+0.010 (0.87%)
At close: Jul 26, 2024, 4:00 PM
1.140
-0.020 (-1.72%)
After-hours: Jul 26, 2024, 4:39 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $83.53 million as of July 26, 2024. Its market cap has decreased by -52.02% in one year.
Market Cap
83.53M
Enterprise Value
21.41M
1-Year Change
-52.02%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has decreased from $192.70M to $83.53M, a decrease of -56.65%. That is a compound annual growth rate of -21.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 26, 2024 | 83.50M | 4.11% |
| Dec 29, 2023 | 80.20M | 35.24% |
| Dec 30, 2022 | 59.30M | -90.62% |
| Dec 31, 2021 | 632.30M | 228.13% |
| Jan 27, 2021 | 192.70M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMV Pharmaceuticals | 85.65M |
| BioAtla | 85.62M |
| Clearside Biomedical | 85.19M |
| Protalix BioTherapeutics | 85.05M |
| Cellectar Biosciences | 84.96M |
| Kronos Bio | 83.53M |
| Ikena Oncology | 83.00M |
| Eyenovia | 82.95M |